Hjem › Kræft (alle typer) › Kentucky
Kræft (alle typer) kliniske forsøg i Kentucky
26 studier for Kræft (alle typer) søger deltagere på steder i Kentucky.
Byer i Kentucky
Officiel studietekst (engelsk)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- University of Kentucky Research Foundation, Lexington
- University of Kentucky Healthcare - Markey Cancer Center, Lexington
- University of Kentucky Medical Center, Lexington
- og 1 flere
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06989437A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Saint Elizabeth Medical Center Edgewood, Edgewood
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 18, Lexington
RekruttererFase 3
Alder 18 til 71 · Alle køn · Opdateret 23. sep. 2026 · NCT07504458Pan Tumor Rollover Study
- University of Louisville-James Graham Brown Cancer Center, Louisville
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03899155A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Baptist Health Louisville /ID# 280025, Louisville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07365241Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
- University of Kentucky, Lexington
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 21. sep. 2026 · NCT06423950Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University Of Kentucky, Lexington
- Norton Cancer Institute Louisville Oncology, Louisville
RekruttererFase 2/3
Alle aldre · Alle køn · Opdateret 18. sep. 2026 · NCT03435796Massage, Oncology, Pain, Anxiety, Feasibility
- University of Kentucky, Lexington
Rekrutterer
Alder 18 til 85 · Kvinder · Opdateret 10. sep. 2026 · NCT07502157A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Edgewood
- Research Site, Louisville
RekruttererFase 3
Alder 18 til 130 · Alle køn · Opdateret 8. sep. 2026 · NCT07647328A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- CHI Saint Joseph Cancer Center - East, Lexington
- University of Kentucky Chandler Medical Center, Lexington
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06119581Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Pikeville Medical Center, Pikeville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT06252649A Study of ARC-02 in B-cell NHL
- Norton Cancer Institute, Louisville
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT07691606Project: Every Child for Younger Patients With Cancer
- University of Kentucky/Markey Cancer Center, Lexington
- Norton Children's Hospital, Louisville
RekruttererObservationsstudie
Op til 25 år · Alle køn · Opdateret 25. aug. 2026 · NCT02402244Abatacept in Immune Checkpoint Inhibitor Myocarditis
- University of Kentucky, Lexington
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT05335928Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- Baptist Health Corbin, Corbin
- Commonwealth Cancer Center-Corbin, Corbin
- og 10 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT06580314Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Norton Cancer Institute, Louisville
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 29. jul. 2026 · NCT04198766A Study of ASP1002 in Adults for Treatment of Solid Tumors
- Norton Cancer Institute, Louisville
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. jul. 2026 · NCT05719558Impact of Daily Oral Cannabis Doses in Patients With Cancer
- University of Kentucky, Lexington
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 15. jul. 2026 · NCT06601218EXoPERT EMERALD Clinical Study
- Lexington VA Healthcare System, Lexington
- KCTL, Louisville
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 45 og opefter · Alle køn · Opdateret 1. jul. 2026 · NCT07186296Comprehensive Connected Cancer Care (C4): Intervention Evaluation
- University of Kentucky, Lexington
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 22. jun. 2026 · NCT06326567Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Robley Rex VA Medical Center, Louisville, KY, Louisville
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 17. jun. 2026 · NCT05486572A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- University of Louisville, Louisville
RekruttererFase 1/2
Alder 18 til 70 · Alle køn · Opdateret 11. jun. 2026 · NCT05361174Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- Markey Cancer Center, University of Kentucky, Lexington
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 27. maj 2026 · NCT03089554Beat Childhood Cancer Specimen Banking and Data Registry
- Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alle aldre · Alle køn · Opdateret 3. feb. 2026 · NCT04715178Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- Norton Cancer Institute, Louisville
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 19. dec. 2025 · NCT05270213Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of Kentucky, Lexington
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 27. nov. 2024 · NCT03860883Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.